JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB8805

Anti-pan-AKT antibody

4

(11 Reviews)

|

(1079 Publications)

Rabbit Polyclonal pan-AKT antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Mouse, Human, Rat samples. Cited in 782 publications. Immunogen corresponding to Synthetic Peptide within Human AKT1 aa 450-500 conjugated to Keyhole Limpet Haemocyanin.

View Alternative Names

PKB, RAC, AKT1, RAC-alpha serine/threonine-protein kinase, Protein kinase B, Protein kinase B alpha, Proto-oncogene c-Akt, RAC-PK-alpha, PKB alpha

5 Images
Immunocytochemistry/ Immunofluorescence - Anti-pan-AKT antibody (AB8805)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-pan-AKT antibody (AB8805)

The Akt antibody (ab8805) is used at 1/80 on cultured neonatal rat cardiomyocytes that express a nuclear-targeted Akt construct. The green is Akt antibody, the red is Texas-red™ phalloidin that labels actin filaments.

This image is courtesy of Mark Sussman, Cincinnati, USA

Western blot - Anti-pan-AKT antibody (AB8805)
  • WB

AbReview16499****

Western blot - Anti-pan-AKT antibody (AB8805)

All lanes:

Western blot - Anti-pan-AKT antibody (ab8805) at 1/500 dilution

All lanes:

Lysate prepared from human HT1080 cell line at 10 µg

Secondary

All lanes:

HRP-conjugated donkey polyclonal to rabbit IgG at 1/5000 dilution

Predicted band size: 56 kDa

Observed band size: 57 kDa

true

Exposure time: 6min

This image is a courtesy of Anonymous Abreview

Western blot - Anti-pan-AKT antibody (AB8805)
  • WB

Unknown

Western blot - Anti-pan-AKT antibody (AB8805)

Western blot using Akt antibody ab8805 at 1/500, Goat anti-rabbit IgG peroxidase conjugate at 1/10,000. 20 ug NIH/3T3 whole cell lysate, Gel type 10% NuPage with MOPS buffer developed with Substrate Pierce SuperSignal™ West Pico.

All lanes:

Western blot - Anti-pan-AKT antibody (ab8805)

Predicted band size: 56 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-pan-AKT antibody (AB8805)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-pan-AKT antibody (AB8805)

A : Normal colon tissue
B : Tumour tissue
Akt antibody (ab8805) used at 1/1000 on formalin-fixed paraffin embedded tissue.

Schematic Diagram - Anti-pan-AKT antibody (AB8805)
  • Schematic Diagram

Unknown

Schematic Diagram - Anti-pan-AKT antibody (AB8805)

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

IHC-P, ICC/IF, WB

applications

Immunogen

Synthetic Peptide within Human AKT1 aa 450-500 conjugated to Keyhole Limpet Haemocyanin. The exact immunogen used to generate this antibody is proprietary information.

P31749

Specificity

Pan Anti-AKT Antibody reacts with the AKT from human tissues. Based on sequence we expect this antibody to react as well with rat, mouse, and chicken AKT.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/500 - 1/2000", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/2000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/1000", "ICCIF-species-notes": "<p></p>" }, "Chicken": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Product Specifications
Anti-pan-AKT antibody (ab8805) is a rabbit polyclonal antibody and is validated for use in ICC/IF, IHC-P, WB in human, mouse, rat samples.
Anti-pan-AKT antibody (ab8805) specifically detects pan-AKT (UniProt ID: P31749; Molecular weight: 56kDa) and is sold in 200 µL selling sizes.

Quality and Validation
Abcam's high quality validation processes ensure Anti-pan-AKT antibody (ab8805) has high sensitivity and specificity.
Anti-pan-AKT antibody (ab8805) has been cited over 784 times in peer reviewed journals and is trusted by the scientific community.
Anti-pan-AKT antibody (ab8805) has 11 independent reviews from customers.

Properties and storage information

Form
Liquid
Purity
Whole antiserum
Purification notes
This product was prepared from monospecific antiserum by a delipidation and defibrination.
Storage buffer
pH: 7.2 Preservative: 0.01% Sodium azide Constituents: 98.6% Whole serum, 0.88% Sodium chloride, 0.424% Potassium phosphate solution
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The target known as pan-AKT or AKT pan is a serine/threonine kinase involved in several cellular processes. It is also known by the names AKT1 AKT2 and AKT3 reflecting the different isoforms of the AKT protein. This enzyme is approximately 56 kDa in molecular weight although this may slightly vary depending on the isoform. AKT is widely expressed in many tissues including muscles fat and the brain. Scientists often detect the protein via AKT western blot reconfirming its detailed molecular weight and AKT protein size in different tissue samples.
Biological function summary

The AKT protein plays a significant role in cellular signaling regulating cell growth survival and metabolism. The AKT protein does not function alone; it interacts with various partners and is part of the larger signaling complexes. AKT activation requires binding to phosphatidylinositol (345)-trisphosphate a process which is dependent on phosphoinositide 3-kinase (PI3K). This activation leads to downstream effects that are vital for proper cellular functions such as nutrient uptake and glucose metabolism.

Pathways

AKT is an important player in the PI3K/AKT/mTOR pathway one of the most important signaling pathways controlling cell growth proliferation and survival. Within this pathway AKT interacts with many proteins including mTOR and PTEN helping to mediate its diverse biological effects. Additionally the AKT signaling pathway has links to the insulin signaling pathway where it influences the activity of several key metabolic regulators.

AKT activity has connections to cancer and diabetes. Abnormal AKT activation is a feature of many cancers as it can lead to uncontrolled cell growth and survival. In cancer AKT often works alongside other proteins like p53 which are important in tumor suppression and cell cycle regulation. In diabetes altered AKT signaling affects insulin sensitivity as seen with proteins such as IRS1 that interact with the insulin pathway. Understanding AKT's role in these diseases continues to be a focus for developing targeted therapies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed : 11882383, PubMed : 15526160, PubMed : 15861136, PubMed : 21432781, PubMed : 21620960, PubMed : 31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed : 11882383, PubMed : 15526160, PubMed : 21432781, PubMed : 21620960, PubMed : 29343641, PubMed : 31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed : 11882383, PubMed : 15526160, PubMed : 21432781, PubMed : 21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed : 11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed : 11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed : 11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed : 12150915, PubMed : 12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed : 31548394, PubMed : 33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed : 10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed : 10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed : 10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed : 9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed : 9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed : 12176338, PubMed : 12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed : 19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its : kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed : 17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its : cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed : 20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed : 19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed : 10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed : 10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed : 23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed : 20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed : 18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed : 16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed : 16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed : 20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed : 32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors : forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed : 32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed : 30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed : 15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed : 31204173).
See full target information AKT1

Publications (1079)

Recent publications for all applications. Explore the full list and refine your search

Diabetology & metabolic syndrome 17:374 PubMed41044623

2025

THBS1 regulates the function and insulin sensitivity of HTR8/SVneo cells treated with high glucose through the RhoA/ROCK1 signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yuerong Chai,Jie Tang,Aimin Liu,Qin Zhou

Physiological reports 13:e70553 PubMed40969143

2025

Midkine promotes PDGF-BB-induced proliferation, migration, and glycolysis of airway smooth muscle cells via the PI3K Akt pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yongtian Xu,Wenli Li,Jun Shi,Yanfang Guo

Frontiers in oncology 15:1613596 PubMed40958861

2025

Molecular mechanism of LncRNA MALAT1 in regulating hepatocellular carcinoma progression via the miR-383-5p/PRKAG1 axis and its role in the tumor immune microenvironment.

Applications

Unspecified application

Species

Unspecified reactive species

Rui Zhang,Mingze Li,Shan Lu,Anni Wang,Shujun Zhang

Journal of clinical and translational hepatology 13:555-567 PubMed40937080

2025

CCNE1 Promotes the Progression of Hepatic Precancerous Lesion and the Malignant Phenotype of Hepatocellular Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Kai Zhang,Xue Hu,Lichao Yao,Wenzhi Guo

Drug target insights 19:59-70 PubMed40917740

2025

The Bushenhuoxue formula improves prothrombotic state in recurrent spontaneous abortion: network pharmacology and experimental validation.

Applications

Unspecified application

Species

Unspecified reactive species

Xuan Yang,Shulan Su,Lijing Liu,Pan Liu,Maoqing Lu,Yinuo Wei,Yaqiong Gao

Frontiers in pharmacology 16:1600435 PubMed40918528

2025

Gypenoside XLIX inhibiting PI3K/AKT/FOXO1 signaling pathway mediated neuronal mitochondrial autophagy to improve patients with ischemic stroke.

Applications

Unspecified application

Species

Unspecified reactive species

Yonglei Liu,Hongdie Mao,Zhengguang Sha,Jishuai Zhao,Hui Cai,Rong Xi,Zhenzhu Zhao,Xiaoling Yin,Lin Yang,Changyun Liu

Open medicine (Warsaw, Poland) 20:20251261 PubMed40918151

2025

CircASH1L-mediated tumor progression in triple-negative breast cancer: PI3K/AKT pathway mechanisms.

Applications

Unspecified application

Species

Unspecified reactive species

Haiyan Liu,Jiaming Wu,Jin Gong,Jing Zhu,Jie Liu,Xiaoqing Chen,Shaohua Qu,Jintao Chen,Zhisheng Zhou,Xulong Fan

Scientific reports 15:31331 PubMed40858982

2025

Revealing the protective potential of D-(-)-Quinic acid against thioacetamide-induced hepatic encephalopathy in rats.

Applications

Unspecified application

Species

Unspecified reactive species

Sedat Ciftel,Betul Cicek,Ismail Bolat,Seval Bulut,Serkan Yildirim,Bahadir Suleyman,Musa Qaniyev,Halis Süleyman

Antioxidants (Basel, Switzerland) 14: PubMed40867839

2025

Biomarker-Driven Optimization of Saponin Therapy in MASLD: From Mouse Models to Human Liver Organoids.

Applications

Unspecified application

Species

Unspecified reactive species

Hye Young Kim,Ju Hee Oh,Hyun Sung Kim,Dae Won Jun

ACS omega 10:34528-34538 PubMed40821538

2025

Exploring the Antitumor Mechanisms of Bai-Hua-She-She-Cao and Ban-Zhi-Lian against Head and Neck Squamous Cell Carcinoma: A Study on Natural Anticancer Therapeutics.

Applications

Unspecified application

Species

Unspecified reactive species

Yuchen Zhang,Yuxing Pan,Kunpeng Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com